This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Brown University. Active years: 2005-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Riverside, RI (US) (2005 - 2008)
- Baltimore, MD (US) (2009 - 2010)
- La Jolla, CA (US) (2012)
- San Diego, CA (US) (2010 - 2014)
Company Filing History:
Years Active: 2005-2014
Title: The Innovations of Michael Rafii: Pioneering Treatments for Muscular Dystrophies
Introduction: Michael Rafii, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of biomedical research with a focus on muscular dystrophies and related disorders. With a remarkable portfolio of nine patents, Rafii's innovative work addresses critical challenges in the treatment, prevention, and diagnosis of debilitating neuromuscular conditions.
Latest Patents: Rafii's latest patents detail groundbreaking compositions and methods aimed at treating diseases associated with abnormal levels or activities of biglycan and collagen VI. His inventions also delve into disorders linked to unstable cytoplasmic membranes due to an unstable dystrophin-associated protein complex (DAPC), as well as issues arising from abnormal synapses or neuromuscular junctions. Notably, his work tackles significant diseases such as Duchenne's Muscular Dystrophy and Becker's Muscular Dystrophy, offering new hope for patients facing these challenges.
Career Highlights: Throughout his career, Michael Rafii has been associated with prestigious institutions, including the Brown University Research Foundation and Brown University. His research initiatives and innovative spirit have positioned him at the forefront of medical advancements in neuromuscular disorders.
Collaborations: Rafii has collaborated with esteemed colleagues such as Justin R. Fallon and Beth A. McKechnie. Together, they have combined their expertise to advance the understanding and treatment of muscular dystrophies, fostering a collaborative environment that promotes innovation in the field.
Conclusion: Michael Rafii’s contributions to the field of medicine through his patents and collaborative efforts have paved the way for novel therapeutic strategies addressing muscular dystrophies. His innovative spirit and dedication to scientific research continue to inspire advancements that may significantly improve the quality of life for individuals affected by these disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile